Optiver Holding’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $26M | Buy |
376,802
+280,727
| +292% | +$19.4M | 0.01% | 30 |
|
|
2025
Q1 | $6.67M | Sell |
96,075
-296,994
| -76% | -$20.6M | ﹤0.01% | 51 |
|
|
2024
Q4 | $33.8M | Buy |
393,069
+382,119
| +3,490% | +$32.9M | 0.02% | 17 |
|
|
2024
Q3 | $1.3M | Buy |
+10,950
| New | +$1.3M | ﹤0.01% | 103 |
|
|
2024
Q2 | – | Sell |
-198,440
| Closed | -$25.5M | – | 633 |
|
|
2024
Q1 | $25.5M | Buy |
198,440
+75,655
| +62% | +$9.71M | 0.01% | 20 |
|
|
2023
Q4 | $12.7M | Buy |
+122,785
| New | +$12.7M | 0.01% | 41 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 316 |
|
|
2023
Q2 | – | Sell |
-14,690
| Closed | -$1.17M | – | 295 |
|
|
2023
Q1 | $1.17M | Buy |
+14,690
| New | +$1.17M | ﹤0.01% | 109 |
|
|
2022
Q4 | – | Sell |
-210,486
| Closed | -$10.5M | – | 248 |
|
|
2022
Q3 | $10.5M | Buy |
210,486
+48,714
| +30% | +$2.43M | 0.01% | 34 |
|
|
2022
Q2 | $9.01M | Buy |
161,772
+25,242
| +18% | +$1.41M | 0.01% | 32 |
|
|
2022
Q1 | $7.58M | Buy |
136,530
+11,038
| +9% | +$613K | 0.01% | 31 |
|
|
2021
Q4 | $6.03M | Buy |
125,492
+870
| +0.7% | +$41.8K | 0.01% | 54 |
|
|
2021
Q3 | $5.98M | Buy |
+124,622
| New | +$5.98M | 0.01% | 34 |
|